|
[1]
|
Jin, Y., He, X. and Wu, Y. (2025) Gastrointestinal Cancer: Molecular Pathogenesis and Targeted Therapy. Molecular Biomedicine, 6, Article No. 136. [Google Scholar] [CrossRef]
|
|
[2]
|
Tanabe, S. (2024) Advances in Molecular Mechanisms of Gastrointestinal Tumors. Cancers (Basel), 16, Article No. 1603.
|
|
[3]
|
Smyth, E.C., et al. (2023) Oesophageal Cancer. Nature Reviews Disease Primers, 3, Article No. 17048.
|
|
[4]
|
Baccili Cury Megid, T., Farooq, A.R., Wang, X. and Elimova, E. (2023) Gastric Cancer: Molecular Mechanisms, Novel Targets, and Immunotherapies: From Bench to Clinical Therapeutics. Cancers, 15, Article No. 5075. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Patel, A. and Gulhati, P. (2024) Molecular Landscape and Therapeutic Strategies against Colorectal Cancer. Cancers, 16, Article No. 1551. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Park, N.H. and Chung, Y. (2007) Molecular Mechanisms of Hepatitis B Virus-Associated Hepatocellular Carcinoma. The Korean Journal of Hepatology, 13, Article No. 320. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Dong, D., Yu, X., Xu, J., Yu, N., Liu, Z. and Sun, Y. (2024) Cellular and Molecular Mechanisms of Gastrointestinal Cancer Liver Metastases and Drug Resistance. Drug Resistance Updates, 77, Article ID: 101125. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Ren, Y., Ma, Q., Zeng, X., Huang, C., Ren, J., Li, F., et al. (2024) Single-Cell RNA Sequencing Reveals Immune Microenvironment Niche Transitions during the Invasive and Metastatic Processes of Ground-Glass Nodules and Part-Solid Nodules in Lung Adenocarcinoma. Molecular Cancer, 23, Article No. 263. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Prevarskaya, N., Skryma, R. and Shuba, Y. (2018) Ion Channels in Cancer: Are Cancer Hallmarks Oncochannelopathies? Physiological Reviews, 98, 559-621. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Stokłosa, P., Borgström, A., Kappel, S. and Peinelt, C. (2020) TRP Channels in Digestive Tract Cancers. International Journal of Molecular Sciences, 21, Article No. 1877. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Huang, R., Wang, F., Yang, Y., Ma, W., Lin, Z., Cheng, N., et al. (2019) Recurrent Activations of Transient Receptor Potential Vanilloid-1 and Vanilloid-4 Promote Cellular Proliferation and Migration in Esophageal Squamous Cell Carcinoma Cells. FEBS Open Bio, 9, 206-225. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Du, Y., Song, W., Chen, J., Chen, H., Xuan, Z., Zhao, L., et al. (2019) The Potassium Channel KCa3.1 Promotes Cell Proliferation by Activating SKP2 and Metastasis through the EMT Pathway in Hepatocellular Carcinoma. International Journal of Cancer, 145, 503-516. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Lu, S., Dai, M., Hu, X., Yi, H. and Zhang, Y. (2021) A New Survival Model Based on Ion Channel Genes for Prognostic Prediction in Hepatocellular Carcinoma. Genomics, 113, 171-182. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Halima, A., Vuong, W. and Chan, T.A. (2022) Next-Generation Sequencing: Unraveling Genetic Mechanisms That Shape Cancer Immunotherapy Efficacy. Journal of Clinical Investigation, 132, e154945. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Nandakumar, V. and Mills, J.R. (2019) The Now and Beyond of Tumor Mutational Burden as a Predictor of Response to Immune Checkpoint Inhibitors. Clinical Chemistry, 65, Article No. 357. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Wang, X. and Li, M. (2019) Correlate Tumor Mutation Burden with Immune Signatures in Human Cancers. BMC Immunology, 20, Article No. 4. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Marabelle, A., Fakih, M., Lopez, J., Shah, M., Shapira-Frommer, R., Nakagawa, K., et al. (2020) Association of Tumour Mutational Burden with Outcomes in Patients with Advanced Solid Tumours Treated with Pembrolizumab: Prospective Biomarker Analysis of the Multicohort, Open-Label, Phase 2 KEYNOTE-158 Study. The Lancet Oncology, 21, 1353-1365. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Pedersen, S.F. and Stock, C. (2013) Ion Channels and Transporters in Cancer: Pathophysiology, Regulation, and Clinical Potential. Cancer Research, 73, 1658-1661. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Gao, C., Li, H., Liu, C., Xu, X., Zhuang, J., Zhou, C., et al. (2021) Tumor Mutation Burden and Immune Invasion Characteristics in Triple Negative Breast Cancer: Genome High-Throughput Data Analysis. Frontiers in Immunology, 12, Article 650491. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Costa, B.P., Nunes, F.B., Noal, F.C. and Branchini, G. (2022) Ion Channels in Endometrial Cancer. Cancers, 14, Article No. 4733. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Xiong, Z.G. (2011) Ion Channels as Targets for Cancer Therapy. International Journal of Physiology, Pathophysiology and Pharmacology, 3, 156-166.
|
|
[22]
|
Moore, A.R., Rosenberg, S.C., McCormick, F. and Malek, S. (2020) RAS-Targeted Therapies: Is the Undruggable Drugged? Nature Reviews Drug Discovery, 19, 533-552. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Fruman, D.A., Chiu, H., Hopkins, B.D., Bagrodia, S., Cantley, L.C. and Abraham, R.T. (2017) The PI3K Pathway in Human Disease. Cell, 170, 605-635. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Shao, Q., Zhang, J. and Wang, H. (2025) cacnb1 Alleviates Mepivacaine-Induced Myocardial Ischemia/Reperfusion Injury by Promoting Nrf2 Nuclear Translocation. Molecular Medicine Reports, 33, Article No. 71. [Google Scholar] [CrossRef]
|
|
[25]
|
Fan, J.J., Erickson, A.W., Carrillo-Garcia, J., Wang, X., Skowron, P., Wang, X., et al. (2025) A Forward Genetic Screen Identifies Potassium Channel Essentiality in SHH Medulloblastoma Maintenance. Developmental Cell, 60, 1532-1549.e7. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Ge, R., Tai, Y., Sun, Y., Zhou, K., Yang, S., Cheng, T., et al. (2009) Critical Role of TRPC6 Channels in VEGF-Mediated Angiogenesis. Cancer Letters, 283, 43-51. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Lv, Y., Bu, X., Du, Z., Zhang, Y., Si, Y., Shi, H., et al. (2026) Promotion of Lung Cancer Growth via Glutamate Ionotropic Receptor N-Methyl-D-Aspartate-Type Subunit 2D (GRIN2D). Journal of Thoracic Disease, 18, Article No. 36. [Google Scholar] [CrossRef]
|